NVDAVSPFE• Last 6 Months (Normalized)
NVDA vs PFE (NVIDIA Corporation vs Pfizer Inc.)
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
NVDA Performance $230.36
+26.12%
NVIDIA Corporation
Normalized Baseline0.00%
PFE Performance $28.45
+6.12%
Pfizer Inc.
Normalized Baseline0.00%
Alpha Spread Margin NVDA LEADS
+20%
NVDA outperforming by 20.00%
NVDAPFE
Spread TrajectoryLast 6 Months (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
NVDA PFE
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(126 dates)
| Date | NVDA Price | NVDA Gain (%) | PFE Price | PFE Gain (%) | Spread |
|---|---|---|---|---|---|
| Mar 09, 2026 | $182.65 | +0.00% | $26.81 | +0.00% | +0.00% |
| Mar 10, 2026 | $184.77 | +1.16% | $27.16 | +1.31% | -0.15% |
| Mar 11, 2026 | $186.03 | +1.85% | $27.30 | +1.83% | +0.02% |
| Mar 12, 2026 | $183.14 | +0.27% | $26.86 | +0.19% | +0.08% |
| Mar 13, 2026 | $180.25 | -1.31% | $26.58 | -0.86% | -0.45% |
| Mar 16, 2026 | $183.22 | +0.31% | $26.61 | -0.75% | +1.06% |
| Mar 17, 2026 | $181.93 | -0.39% | $27.45 | +2.39% | -2.78% |
| Mar 18, 2026 | $180.40 | -1.23% | $27.32 | +1.90% | -3.13% |
| Mar 19, 2026 | $178.56 | -2.24% | $27.41 | +2.24% | -4.48% |
| Mar 20, 2026 | $172.70 | -5.45% | $26.97 | +0.60% | -6.05% |
| Mar 23, 2026 | $175.64 | -3.84% | $26.77 | -0.15% | -3.69% |
| Mar 24, 2026 | $175.20 | -4.08% | $26.96 | +0.56% | -4.64% |
| Mar 25, 2026 | $178.68 | -2.17% | $27.28 | +1.75% | -3.92% |
| Mar 26, 2026 | $171.24 | -6.25% | $27.57 | +2.83% | -9.08% |
| Mar 27, 2026 | $167.52 | -8.28% | $27.04 | +0.86% | -9.14% |
Page 1 of 9